ww and semaglutide WeightWatchers offers version of Ozempic, despite FDA concerns Wegovy® pill, accessible through Weight

Results were presented at ObesityWeek 2025 and published in The Lancet , and Lilly indicated plans to begin Phase 3 enrollment by the end of 2025 ( Eli Lilly investor release )

If you are trying to decide between the two medications, understanding the differences in how they work is essential

Accepting current results if close to but not at ideal goal

Being on hormone replacement therapy has helped more women have meaningful responses to these medications

Here are some points to consider: Factors to Weigh Hormone Sensitivity: If you are sensitive to estrogen, Junel Fes lower dose may be preferable

GoodRx is not available outside of the United States and therefore, access to the site is blocked